Skip to main content

RETRACTABLE TECHNOLOGIES INC

For the period ended Mar 31, 2025. Filed May 15, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 15, 2025

RVP$0.57-0.1%Stored close · as of Nov 6, 2026

What changed in Risk Factors?

Read the current filing

Previous report: 10-Q

Period ended 2024-09-30; filed 2024-11-14.

0001558370-24-015682

Item 1A. Risk Factors

Current report: 10-Q

Period ended 2025-03-31; filed 2025-05-15.

0001558370-25-007853

Item 1A. Risk Factors

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 3 previous paragraphs and 2 current paragraphs.

1 unchanged; 1 reworded; 0 added; 1 removed; 0 previous and 0 current paragraphs rearranged.

Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

The current filing states there were no material changes to risk factors.

This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.

Current filing’s statement

There were no material changes in our Risk Factors as set forth in our most recent annual report which is available on EDGAR.
Removed paragraphs (1)

Previous report

Recently enacted tariffs on our products are expected to have a material negative impact to our results of operations and financial position. We are working to lessen the financial impact of the tariffs, including shifting a larger portion of manufacturing of 1mL, 3mL, and EasyPoint® needles to our domestic manufacturing facility, but these actions will be expensive and the timeline remains uncertain. Likewise, our lawsuit to exempt our payment of tariffs may not succeed. Consequently, we expect a material increase in costs which is expected to materially impact our operations and may impact long-term viability.
Reworded paragraphs (1)

Previous wording

In addition to the risk factors disclosed in our most recent annual report which is available on EDGAR, the following additional risk factor has been identified.

Current wording

There were no material changes in our Risk Factors as set forth in our most recent annual report which is available on EDGAR.